Compare CETX & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CETX | VIVS |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | 11 |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 3.8M |
| IPO Year | 2016 | 2010 |
| Metric | CETX | VIVS |
|---|---|---|
| Price | $2.44 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.0K | ★ 722.2K |
| Earning Date | 05-12-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,628,200.00 | $4,603,000.00 |
| Revenue This Year | $20.41 | $42.38 |
| Revenue Next Year | N/A | $15.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 28.73 | 8.82 |
| 52 Week Low | $0.37 | $0.26 |
| 52 Week High | $9.70 | $5.30 |
| Indicator | CETX | VIVS |
|---|---|---|
| Relative Strength Index (RSI) | 39.59 | 38.51 |
| Support Level | $2.43 | $0.27 |
| Resistance Level | $3.21 | $0.58 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 21.51 | 87.54 |
Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.